UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

~~THE~~Date ~~SECURITIES~~of ~~EXCHANGE~~Report ~~ACT~~(Date OFof earliest ~~1934~~event reported): August 23, 2004

Date of Report (Date of earliest event reported): April 21, 2004

HealthGate Data Corp.

(Exact name of registrant as specified in its charter)

Commission file number 0-28701

Delaware		0-28701		04-3220927
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

Delaware		04-3220927
(state or other jurisdiction of incorporation)		(IRS employer identification no.)

25 Corporate Drive, Suite 310, Burlington, Massachusetts 01803

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (781) 685-4000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

HealthGate Data Corp.

~~FORM~~Form 8-K

Item 128.01 ~~Results~~Other ~~of Operations and Financial Condition~~Events

On ~~April~~August 2124, 2004, HealthGate Data Corp. (the “Company”) issued a ~~press~~ press release announcing that the Company’s ~~financial~~had ~~results~~forged ~~for~~a ~~the~~worldwide ~~quarter~~distribution agreement ~~ended~~with ~~March~~EBSCO Publishing. ~~31,~~Additionally ~~2004~~HealthGate announced that EBSCO Publishing has acquired the assets of The Natural Pharmacist complementary and alternative medicine database. A copy of the press release is furnished as Exhibit 99.1 and incorporated by reference herein.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, ~~thereunto~~hereunto duly authorized.

	HealthGate Data Corp.
Date: April 21, 2004	By:	/s/ William S. Reece
Date: August 24, 2004	By:	/s/ William S. Reece
		William S. Reece	~~William S. Reece~~
		Chairman and Chief Executive Officer	~~Chairman and Chief Executive Officer~~
	By:	~~/s/ Veronica Zsolcsak~~	/s/ Veronica Zsolcsak
		~~Veronica Zsolcsak~~	Veronica Zsolcsak
		~~Chief Financial Officer~~	Chief Financial Officer

EXHIBIT INDEX

Exhibit No.		Description
99.1		Press release dated ~~April~~August 2124, 2004 ~~containing~~announcing ~~the~~EBSCO ~~financial~~Publishing’s ~~results~~acquisition ~~for~~of ~~quarter~~HealthGate’s ~~ended~~The ~~March~~Natural ~~31,~~Pharmacist® ~~2004.~~and an exclusive distribution agreement to distribute HealthGate’s Consumer Health Library content to academic and public libraries

Filing Compare · HEALTHGATE DATA CORP